Viking Therapeutics Inc.

NASDAQ: VKTX · Real-Time Price · USD
40.04
-0.20 (-0.50%)
At close: Aug 15, 2025, 3:59 PM
40.74
1.75%
After-hours: Aug 15, 2025, 07:57 PM EDT

Viking Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-171.55M -128.24M -109.96M -99.15M -96.75M -93.72M -85.89M -80.85M -74.09M -72.3M -68.87M -61.66M -59.13M -57.08M -54.99M -53.58M -49.63M -43.82M
Depreciation & Amortization
-5.28M 383K 346K 310K 296K 294K 292K 290K 359K 286K 291K 295K 228K 301K 296K 291K 286K 281K
Stock-Based Compensation
39.54M 33.08M 29.71M 28.13M 23.62M 21.16M 16.75M 14.83M 12.29M 9.88M 8.67M 7.95M 7.61M 6.88M 6.1M 5.71M 5.58M 5.74M
Other Working Capital
-10.96M -24.83M 6.36M 16.49M 9.39M 26.48M 12.97M 10.39M 11.99M 7.09M 3.1M 1.13M -748K 902K -383K 2.37M 3.06M 3.3M
Other Non-Cash Items
-16.68M -31.26M -13.06M -9.03M -3.95M 128K -258K -369K -186K -217K 818K 905K 677K 689K 29K 45K 105K 109K
Deferred Income Tax
n/a n/a n/a -2.7M -5.85M -7.81M -7.81M -5.11M -1.97M n/a n/a 755K 1.73M 2.77M 3.91M 4.37M 4.47M 4.27M
Change in Working Capital
1.42M -6.59M 9.36M 12.38M 14.87M 27.9M 3.55M 4.55M 3.09M -668K 10.19M 1.44M 1.15M -795K -2.93M 2.45M 4.06M 5.06M
Operating Cash Flow
-152.53M -133.99M -87.79M -74.25M -71.94M -54.87M -73.38M -66.66M -60.5M -62.51M -48.4M -49.82M -47.25M -47.24M -47.59M -40.72M -35.12M -28.35M
Capital Expenditures
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-643.03M -749.38M -1.11B -1.07B -1B -1.02B -478.3M -425.38M -356.42M -148.14M -121.43M -112.39M -126.12M -150.02M -168.01M -165.41M -249.92M -272.88M
Sales Maturities Of Investments
321.89M 425.66M 560M 549.72M 440.7M 376.43M 299.22M 217.82M 188.29M 203.48M 176.18M 187.3M 187.74M 196.23M 205.97M 206.23M 267.49M 296.67M
Other Investing Acitivies
459.38M 167.33M 10.1M 10.13M 10.12M 135.97M -179.09K -207.56K -168.13K 19.02M 20.63M 48.04M 61.63M 46.21M 37.96M 40.82M 17.57M 23.79M
Investing Cash Flow
138.24M -30.33M -553.37M -524.22M -562.65M -641.08M -179.09M -207.56M -168.13M 55.33M 54.75M 74.9M 61.63M 46.21M 37.96M 40.82M 17.57M 23.79M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
42.1K 42.1K 42.1K 42.1K n/a 37K n/a -1.03K -1.03K -1.71M -6.8M -6.79M -6.79M -5.12M -473K -473K -642K -642K
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
4.38M 6.78M 15.35M -32.13M 10.04M 4.34M 1.32M 11.88M 13.86M 16.73M 10.95M 246K 12K 1.83M 6.9M 7.32M 7.59M 6.11M
Financial Cash Flow
4.38M 6.78M 612.46M 611.65M 609.06M 873.23M 271.38M 281.94M 282.02M 13.35M 4.16M -6.54M -6.8M -3.32M 6.88M 7.3M 7.59M 6.11M
Net Cash Flow
-10.04M -157.64M -28.84M 13.16M -25.6M 177.22M 18.88M 7.78M 53.29M 5.91M 10.26M 18.14M 7.4M -4.35M -2.75M 7.39M -9.96M 1.54M
Free Cash Flow
-152.53M -133.99M -87.79M -74.25M -71.94M -54.87M -73.38M -66.66M -60.5M -62.51M -48.4M -49.82M -47.25M -47.24M -47.59M -40.72M -35.12M -28.35M